发明名称 Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors
摘要 The present invention provides compounds of Formula I or a pharmaceutical salt thereof, where the variables for R1, R2, and R3 are as described herein; methods of treating a condition such as hypertriglyceridemia; and processes for preparing the compounds.;
申请公布号 US9073856(B2) 申请公布日期 2015.07.07
申请号 US201314372606 申请日期 2013.01.16
申请人 Eli Lilly and Company 发明人 Fernandez Maria Carmen;Gonzalez-Garcia Maria Rosario;Liu Bin;Pfeifer Lance Allen
分类号 C07D211/18;A61K31/445;C07D211/14;C07D401/04;C07D417/04;C07D277/64;C07D295/03;C07D211/42;C07D211/44;C07D213/06;C07D213/24;C07D211/46 主分类号 C07D211/18
代理机构 代理人 Myers James B.
主权项 1. A compound of the formula below:wherein R1 is selected from: —CH3 and —CF3; R2 is selected from H, —C1-4alkyl, —C3-4cycloalkyl, —C1-2alkylcyclopropyl, —O—C1-2alkyl, phenyl, 2-benzothiazolyl, 2-pyridinyl, and 3-pyridinyl, wherein the phenyl is optionally substituted with 1 or 2 groups independently selected from: halogen, —C1-2alkyl, —CF3, —OC1-3alkyl, and —OC1-2haloalkyl, and the pyridinyl is optionally substituted with 1 or 2 groups independently selected from —CH3, halogen, —OCH2cyclopropyl, and —OC1-3alkyl; and R3 is selected from: H, —OC1-4alkyl, —OC1-3alkyl, —OC1-2haloalkyl, phenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, and 2-thiazolyl, wherein the phenyl is optionally substituted with a halogen; provided that if one of R2 and R3 is H then the other one of R2 and R3 is not H; or a pharmaceutically acceptable salt thereof.
地址 Indianapolis IN US